S. 5002 · 117th Congress
FDA Modernization Act 2.0
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Passed the Senate without a recorded vote, then expired. It passed by voice vote or unanimous consent, which don't record how each member voted, but didn't become law before the 117th Congress ended.
11 cosponsors · 3 D, 6 R, 2 I
11 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- Senate Introduced Sep 29, 2022
- Senate Passed Sep 29, 2022
This bill authorizes the use of certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug.
What it does: CRS summary · Passed Senate · Sep 29, 2022
FDA Modernization Act 2.0
This bill authorizes the use of certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug.
The bill also removes a requirement to use animal studies as part of the process to obtain a license for a biological product that is biosimilar or interchangeable with another biological product.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: FDA Modernization Act 2.0
Latest action (Sep 29, 2022): Held at the desk.
Policy area: Health · Origin: Senate · Introduced: Sep 29, 2022
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
- Senate Introduced Sep 29, 2022
- Senate Passed Sep 29, 2022
No recorded floor vote found.